Brief: Sprint Bioscience: SEK 3.8 mln grant for treatment against leukemia
Dec 10 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Gets 3.8 million in Vinnova-grant for new treatment against leukemia
* Will use the grant to further develop PIP4K2a-project
Source text for Eikon: ID:nWkrli1501
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program